Astellas is putting up some cash to use one of 4D Molecular Therapeutics’ gene therapy vectors for at least one rare eye disease.

Humans can see 3-D images with only one eye, according to new research, suggesting a future in which the technology could become cheaper and more accessible.

A few weeks back, I received an email from a reader who was blind in one eye and wanted to know how the Oculus Rift would work for him. I thought it was an interesting question but honestly didn't ...

Safe and reproducible delivery of gene therapy vector into the subretinal space is essential for successful targeting of the retinal pigment epithelium (RPE) and photoreceptors. The success of ...

The eye receiving the AAV2/4.hrpe65 vector showed very distinct RPE65 labeling in the RPE cells of the treated area . No other cells showed RPE65 protein expression; in particular, the ...